CRMD
CorMedix·NASDAQ
--
--(--)
--
--(--)
10.26 / 10
Outperform
Analyst consensus is a 100% Strong Buy from Needham, with a sentiment score of 10.26. Fund‑flow rating is good (7.55) showing overall positive inflows, though medium‑size investors are net negative. Overall sentiment remains highly bullish.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-05
InstitutionNeedham
Times predicted6
Historical Win Rate66.7%
Is money flowing into or out of CRMD?
- CRMD holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 10.26/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
